BTK Inhibitors as Sensitizing Agents in Solid Tumors

BTK Inhibitors as Sensitizing Agents in Solid Tumors

Abdallah, Al-Ola A.; Kaur, Varinder; Dreicer, Robert

Elsevier Science & Technology

09/2024

Dura

Inglês

9780323952392

15 a 20 dias

Descrição não disponível.
1. Overview of BTK pathway
2. Overview of BTK inhibitors and their clinical utility [1st gen, 2nd gen]
3. Mechanisms of therapy resistance in cancer cells
4. BTK inhibitors in paclitaxel and docetaxel resistance
5. BTK inhibitors in Platinum resistance
6. BTK inhibitors in BRAF resistance
7. BTK inhibitors in radio-resistance
8. Ibrutinib beyond BTK inhibition and role in immunotherapy resistance
9. Novel BTK inhibitors and future perspectives
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Cancer; chemotherapy; immunotherapy; multi-drug resistance; sensitizing agent; BTK; ibrutinib; paclitaxel; docetaxel; platinum; BRAF